Drug discovery service provider Schrödinger files for $100M IPO 20-Jan-2020 By Nick Taylor Schrödinger files for $100m IPO after establishing itself as a drug discovery partner to big pharma.
Bayer, Schrödinger partner on compound developing software project 13-Jan-2020 By Vassia Barba Bayer to work with Schrödinger on a molecule design software, which will be integrated into the latter’s LiveDesign, a digital drug design platform.
Schrödinger extends drug discovery partnership with Morphic 20-Aug-2019 By Vassia Barba Schrödinger secures further funding, extends collaboration with Morphic Therapeutic on computational discovery platform for oral integrin drugs for the second time.